Barely Significant
← all excerpts

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.

Nat Med · 2024 · PMC11031401 · PMID 38584166

2
hedged sentences
closest p
boldest claim

The sentences

an increasing trendno p-value reported
Boolean gating confirmed an increasing trend of active (CD69 + CD107a + ) (Fig. 3e ) and proliferative (Ki67 + ) (Fig. 3f ) polyfunctional CD4 + and CD8 + T cells with cytolytic capabilities (GZMA + PRF1 + ) after stimulation.

also in 63,971 other papers

showed a trendno p-value reported
Patients with CR or PR showed a trend toward a greater magnitude of IFNγ response (Extended Data Fig. 7c ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.